Research2h ago
Cambridge Tests First AI-Designed Vaccine In Humans
Researchers at the University of Cambridge developed a new vaccine using artificial intelligence and transitioned it to human trials. This milestone validates the use of computational design for rapid antigen discovery. Practitioners can now expect shorter development cycles for targeted immunotherapies. The shift from theoretical modeling to clinical testing proves the practical utility of AI in vaccinology.